Genotyping Market
Genotyping Market by Products (Kits, Reagents and Instruments), by Technology (Mass Spectrometry, Microarray, Sequencing, PCR, Electrophoresis, and Others) by Application (Drug Discovery, Personalized Medicine, Pharma Genomics, and Diagnostic Research) – Global Trends, Industry Size, Share, Growth and Forecast, 2019-2025
Genotyping market is expected to grow at a significant rate during the forecast period 2019-2025. The genotyping technologies offer tool set to examine a wide range of genetic variation. The analysis of genetic variation and genomic profiling can be done by a broad range of products such as microarray and DNA sequencer. Genotyping is used to determine the gene variants associated with the disease. The microarray technology is used in modern research laboratories, and the technology is derived from Southern blotting. The technology is a collection of microscopic elements such as DNA, RNA, or proteins and it can be probed with target molecules to develop data based on the gene expression. Genotyping allows researchers and scientist to understand the genome sequence and analyze the function and structure of a large number of genes. Function and structure allow scientists to understand gene expression.
The advances in bioinformatics, pharmacogenomics has emerged as a platform for drug discovery and clinical development with significant therapeutic and psychosocial implications. Pharmacogenomics is defined as a study between specific DNA-sequence variation and drug effect. It enables in improvising drug discovery and development process. The increasing technological advancements are considered as the major factor for the growth of the genotyping market. The increasing use of genotyping in personalized medicine and drug discovery is also contributing to the growth of the market. the genotyping market is segmented on the basis of technology which includes microarray, mass spectrometry, sequencing, PCR (polymer chain reaction), electrophoresis, and others. Microarray technology is used in various applications such as gene discovery, drug discovery, disease diagnosis, and toxicological research.
Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is dominating due to the adoption of advanced technology and advanced healthcare infrastructure. The increasing R& D projects in the region, the genotypic research enables to expand genomics and bioinformatics technologies and develops applications for biomedical research. The main initiatives of the project are to reduce the cost of experiments and enables to conduct cutting edge research. However, in Asia-Pacific awareness about genotyping is increasing, as genotyping tests enables to control of genetic diseases.
There are various companies involved in the genotyping such as Deep Genomics, Fluidigm Corp., GE Healthcare, Illumina, Inc., Integrated DNA Technologies, Inc., Intellia Therapeutics Inc. and so on. The companies are focused on developing advanced genotyping technologies to stay competitive in the market. Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players. For instance: In January 2017, Illumina, the provider of next-generation sequencing technology introduced NovaSeq series global leader in next-generation sequencing technology, today introduced the NovaSeq Series, which is scalable sequencing architecture enables $100 genome.
Research methodology:
The market study of the global genotyping market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include:
- Financial reports of companies involved in the market
- Authentic Public Databases such as the Organisation for Economic Co-operation and Development (OECD), World Health Organization (WHO), and others
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog.
The report is intended for research organizations, biotechnology companies, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
Market segmentation:
- Global Genotyping Market Research and Analysis by Product
- Global Genotyping Market Research and Analysis by Technology
- Global Genotyping Market Research and Analysis by Application
The report covers:
- Comprehensive research methodology of the global genotyping market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global genotyping market.
- Insights about market determinants which are stimulating the global genotyping market.
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Thermo Fisher Scientific, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. PerkinElmer, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Agilent Technologies, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Merck KGaA
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. GE Healthcare
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Genotyping Market by Products
5.1.1. Reagents & Kits
5.1.2. Instruments
5.2. Global Genotyping Market by Technology
5.2.1. Mass Spectrometry
5.2.2. Microarray
5.2.3. Sequencing
5.2.4. Polymerase Chain Reaction
5.2.5. Electrophoresis
5.2.6. Others
5.3. Global Genotyping Market by Application
5.3.1. Drug Discovery
5.3.2. Personalized Medicine
5.3.3. Diagnostic Research
5.3.4. Pharma Genomics
5.3.5. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Agilent Technologies, Inc.
7.2. Bio-Rad Laboratories, Inc.
7.3. CRISPR Therapeutics AG
7.4. Danaher Corporation
7.5. Deep Genomics
7.6. Eurofins GSC Lux SARL
7.7. Fluidigm Corp.
7.8. General Electric Co.
7.9. GENEWIZ
7.10. Illumina, Inc.
7.11. Integrated DNA Technologies, Inc.
7.12. Intellia Therapeutics Inc.
7.13. Merck KGaA
7.14. Pacific Biosciences of California, Inc.
7.15. Pathway Genomics Corp.
7.16. PerkinElmer, Inc.
7.17. QIAGEN N.V.
7.18. Quantabio
7.19. Roche Molecular Systems, Inc.
7.20. Thermo Fisher Scientific, Inc.
1. GLOBAL GENOTYPING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
2. GLOBAL REAGENT & KITS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL GENOTYPING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
5. GLOBAL MASS SPECTROMETRY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
6. GLOBAL MICRO ARRAY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
8. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL ELECTROPHORESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL GENOTYPING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
12. GLOBAL DRUG DISCOVERY RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL PERSONALIZED MEDICINE RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
14. GLOBAL DIAGNOSTIC RESEARCH RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
15. GLOBAL PHARMA GENOMICS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
16. GLOBAL OTHERS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
17. GLOBAL GENOTYPING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
18. NORTH AMERICAN GENOTYPING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
19. NORTH AMERICAN GENOTYPING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
20. NORTH AMERICAN GENOTYPING MARKET RESEARCH AND ANALYSIS TECHNOLOGY, 2018-2025 ($ MILLION)
21. NORTH AMERICAN GENOTYPING MARKET RESEARCH AND ANALYSIS BY APPLICATION,2018-2025 ($ MILLION)
22. EUROPEAN GENOTYPING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
23. EUROPEAN GENOTYPING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
24. EUROPEAN GENOTYPING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
25. EUROPEAN GENOTYPING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($
26. ASIA-PACIFIC GENOTYPING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
27. ASIA-PACIFIC GENOTYPING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
28. ASIA-PACIFIC GENOTYPING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
29. ASIA-PACIFIC GENOTYPING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
30. REST OF THE WORLD GENOTYPING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025($ MILLION)
31. REST OF THE WORLD GENOTYPING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025($ MILLION)
32. REST OF THE WORLD GENOTYPING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
1. GLOBAL GENOTYPING MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
2. GLOBAL GENOTYPING MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
3. GLOBAL GENOTYPING MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
4. GLOBAL GENOTYPING MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
5. US GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
6. CANADA GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
7. UK GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
8. FRANCE GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
9. GERMANY GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
10. ITALY GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
11. SPAIN GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
12. ROE GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
13. INDIA GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
14. CHINA GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
15. JAPAN GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF ASIA-PACIFIC GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
17. REST OF THE WORLD GENOTYPING MARKET SIZE, 2018-2025 ($ MILLION)
